- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 9P2: 1-(1,3-benzodioxol-5-yl)-~{N}-(1,3-benzodioxol-5-ylmethyl)-~{N}-[(3-butyl-2,5-diphenyl-imidazol-4-yl)methyl]methanamine(Non-covalent)
- 3 x TLA: L(+)-TARTARIC ACID(Non-covalent)
TLA.2: 9 residues within 4Å:- Chain A: T.40, I.41, N.42, R.119, E.296, E.297, S.298, V.299, R.301
8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:I.41, A:N.42, A:E.296, A:S.298, A:V.299, A:V.299
- Salt bridges: A:R.119, A:R.301
TLA.3: 7 residues within 4Å:- Chain A: T.200, W.201, A.203, R.204, T.206, R.207, S.208
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:T.200, A:S.208
- Salt bridges: A:R.204
TLA.20: 8 residues within 4Å:- Chain B: R.39, T.40, I.41, R.119, E.297, S.298, V.299, R.301
9 PLIP interactions:9 interactions with chain B- Hydrogen bonds: B:I.41, B:R.119, B:E.297, B:E.297, B:S.298, B:V.299, B:V.299
- Salt bridges: B:R.119, B:R.301
- 32 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)
OLA.4: 12 residues within 4Å:- Chain A: W.45, A.103, D.104, L.107, W.114, R.119, G.120, L.123, A.124, L.127
- Chain B: L.123, I.126
Ligand excluded by PLIPOLA.5: 6 residues within 4Å:- Chain A: F.106, F.110, K.111, T.188
- Chain B: I.126
- Ligands: OLA.6
Ligand excluded by PLIPOLA.6: 4 residues within 4Å:- Chain A: L.189
- Ligands: 9P2.1, OLA.5, OLA.23
Ligand excluded by PLIPOLA.7: 1 residues within 4Å:- Chain A: A.34
Ligand excluded by PLIPOLA.8: 3 residues within 4Å:- Chain A: P.61, T.65, Q.69
Ligand excluded by PLIPOLA.9: 1 residues within 4Å:- Chain A: V.13
Ligand excluded by PLIPOLA.10: 1 residues within 4Å:- Chain A: I.175
Ligand excluded by PLIPOLA.11: 8 residues within 4Å:- Chain A: L.187, T.190, I.191, T.194, F.195, L.198, R.199, S.202
Ligand excluded by PLIPOLA.12: 5 residues within 4Å:- Chain A: T.190, T.194, L.197, W.201
- Ligands: OLA.17
Ligand excluded by PLIPOLA.13: 7 residues within 4Å:- Chain A: K.213, A.217, S.221, I.224, I.266
- Ligands: OLA.14, OLA.17
Ligand excluded by PLIPOLA.14: 5 residues within 4Å:- Chain A: V.17, I.262, I.270, V.273
- Ligands: OLA.13
Ligand excluded by PLIPOLA.15: 4 residues within 4Å:- Chain A: L.178, L.183, V.231, M.235
Ligand excluded by PLIPOLA.16: 8 residues within 4Å:- Chain A: G.122, A.129, V.130, G.133, L.134
- Ligands: OLA.18, 9P2.19, OLA.24
Ligand excluded by PLIPOLA.17: 6 residues within 4Å:- Chain A: L.186, V.216, A.220, F.223
- Ligands: OLA.12, OLA.13
Ligand excluded by PLIPOLA.18: 1 residues within 4Å:- Ligands: OLA.16
Ligand excluded by PLIPOLA.21: 4 residues within 4Å:- Chain B: F.106, W.114, C.192
- Ligands: OLA.22
Ligand excluded by PLIPOLA.22: 6 residues within 4Å:- Chain A: I.126
- Chain B: A.99, W.184
- Ligands: 9P2.19, OLA.21, OLA.24
Ligand excluded by PLIPOLA.23: 8 residues within 4Å:- Chain B: G.122, W.125, I.126, A.129, W.132
- Ligands: OLA.6, OLA.28, OLA.29
Ligand excluded by PLIPOLA.24: 4 residues within 4Å:- Chain B: L.180, W.184
- Ligands: OLA.16, OLA.22
Ligand excluded by PLIPOLA.25: 8 residues within 4Å:- Chain B: W.45, T.100, A.103, D.104, L.107, L.127
- Ligands: 9P2.19, OLA.26
Ligand excluded by PLIPOLA.26: 9 residues within 4Å:- Chain A: W.114, F.118
- Chain B: L.107, W.114, C.115, F.118, R.119, L.123
- Ligands: OLA.25
Ligand excluded by PLIPOLA.27: 5 residues within 4Å:- Chain B: I.82, L.86, I.140, A.143, L.144
Ligand excluded by PLIPOLA.28: 5 residues within 4Å:- Chain B: K.38, W.125, W.132
- Ligands: OLA.23, OLA.35
Ligand excluded by PLIPOLA.29: 1 residues within 4Å:- Ligands: OLA.23
Ligand excluded by PLIPOLA.30: 7 residues within 4Å:- Chain B: L.186, L.187, T.190, I.191, F.195, L.198
- Ligands: OLA.32
Ligand excluded by PLIPOLA.31: 4 residues within 4Å:- Chain B: T.194, L.197, L.198, W.201
Ligand excluded by PLIPOLA.32: 4 residues within 4Å:- Chain B: L.183, L.186, I.234
- Ligands: OLA.30
Ligand excluded by PLIPOLA.33: 7 residues within 4Å:- Chain B: K.213, V.216, A.217, I.224, F.225, F.259
- Ligands: OLA.34
Ligand excluded by PLIPOLA.34: 8 residues within 4Å:- Chain B: K.210, K.213, I.266, I.269, I.270, V.273, A.274
- Ligands: OLA.33
Ligand excluded by PLIPOLA.35: 5 residues within 4Å:- Chain B: A.34, A.37, V.51, W.125
- Ligands: OLA.28
Ligand excluded by PLIPOLA.36: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPOLA.37: 8 residues within 4Å:- Chain A: L.137, L.138, P.141
- Chain B: L.137, P.141, Y.145, Y.163, V.173
Ligand excluded by PLIP- 1 x CIT: CITRIC ACID(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Robertson, N. et al., Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727. Nature (2018)
- Release Date
- 2018-01-10
- Peptides
- C5a anaphylatoxin chemotactic receptor 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.70 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 9P2: 1-(1,3-benzodioxol-5-yl)-~{N}-(1,3-benzodioxol-5-ylmethyl)-~{N}-[(3-butyl-2,5-diphenyl-imidazol-4-yl)methyl]methanamine(Non-covalent)
- 3 x TLA: L(+)-TARTARIC ACID(Non-covalent)
- 32 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)
- 1 x CIT: CITRIC ACID(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Robertson, N. et al., Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727. Nature (2018)
- Release Date
- 2018-01-10
- Peptides
- C5a anaphylatoxin chemotactic receptor 1: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.